Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome.
Yagmur
Rezzan
R
Esen
Figen
F
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy* / Q000382:microbiology; D002552:Cerebral Ventricles / Q000382:microbiology*; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects; D003091:Colistin / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D003091:Colistin